Retrieve available abstracts of 20 articles: HTML format
Single Articles
August 2025
LI Z, Zhang H, Chen Z, Wu G, et al MicroRNA?21: A potential therapeutic target in lung cancer (Review).
Int J Oncol. 2025;67:67. PubMedAbstract available
June 2025
WANG SQ, Zhao BX, Liu Y, Wang YT, et al [Corrigendum] New application of an old drug: Antitumor activity and mechanisms
of doxycycline in small cell lung cancer.
Int J Oncol. 2025;66:48. PubMedAbstract available
SHEN W, Pang H, Xin B, Duan L, et al [Corrigendum] Biological effects of BMP7 on small?cell lung cancer cells and its
bone metastasis.
Int J Oncol. 2025;66:51. PubMedAbstract available
May 2025
YAN H, He Q, Gao Y, He X, et al SLC4A7 suppresses lung adenocarcinoma oncogenesis by reducing lactate transport
and protein lactylation.
Int J Oncol. 2025;66:33. PubMedAbstract available
April 2025
ZHENG Y, Wang K, Mao W, Zhang G, et al Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA
N6?methyladenosine?mediated post?transcriptional regulation.
Int J Oncol. 2025;66:27. PubMedAbstract available
KAEWPIBOON C, Surapinit S, Malilas W, Moon E, et al [Retracted] Feroniellin A?induced autophagy causes apoptosis in
multidrug?resistant human A549 lung cancer cells.
Int J Oncol. 2025;66:30. PubMedAbstract available
March 2025
XI Y, Zeng S, Tan X, Deng X, et al Curcumin inhibits the activity of ubiquitin ligase Smurf2 to promote
NLRP3?dependent pyroptosis in non?small cell lung cancer cells.
Int J Oncol. 2025;66:21. PubMedAbstract available
ANDREIKOS D, Spandidos DA, Georgakopoulou VE Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and
emerging therapeutic strategies (Review).
Int J Oncol. 2025;66:23. PubMedAbstract available
January 2025
KIM H, Jung SH, Jo S, Han JW, et al Anti?angiogenic effect of Bryopsis plumosa?derived peptide via aquaporin 3 in
non?small cell lung cancer.
Int J Oncol. 2025;66:5. PubMedAbstract available
WANG Y, Fleishman JS, Li Y, Cao Y, et al Non?coding RNA?mediated epigenetic modification of ferroptosis in non?small cell
lung cancer (Review).
Int J Oncol. 2025;66:8. PubMedAbstract available
November 2024
SUN Y, Lian Y, Mei X, Xia J, et al Cinobufagin inhibits M2?like tumor?associated macrophage polarization to
attenuate the invasion and migration of lung cancer cells.
Int J Oncol. 2024;65:102. PubMedAbstract available
August 2024
ZHANG W, Liu K, Pei Y, Ma J, et al [Retracted] Mst1 regulates non?small cell lung cancer A549 cell apoptosis by
inducing mitochondrial damage via ROCK1/F?actin pathways.
Int J Oncol. 2024;65:75. PubMedAbstract available
WU S, Zhao Q, Liu S, Kuang J, et al Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity
of cisplatin by stimulating oxidative stress in non?small cell lung cancer.
Int J Oncol. 2024;65:77. PubMedAbstract available
July 2024
TAYLOR J, Dubois F, Bergot E, Levallet G, et al Targeting the Hippo pathway to prevent radioresistance brain metastases from the
lung (Review).
Int J Oncol. 2024;65:68. PubMedAbstract available
June 2024
TAI F, Zhai R, Ding K, Zhang Y, et al Long non?coding RNA lung cancer?associated transcript 1 regulates ferroptosis via
microRNA?34a?5p?mediated GTP cyclohydrolase 1 downregulation in lung cancer
cells.
Int J Oncol. 2024;64:64. PubMedAbstract available
April 2024
XIE L, Xie D, Du Z, Xue S, et al A novel therapeutic outlook: Classification, applications and challenges of
inhalable micron/nanoparticle drug delivery systems in lung cancer (Review).
Int J Oncol. 2024;64:38. PubMedAbstract available
March 2024
LI S, Li Z, Huang L, Geng Z, et al SLCO4A1, as a novel prognostic biomarker of non?small cell lung cancer, promotes
cell proliferation and migration.
Int J Oncol. 2024;64:30. PubMedAbstract available
WU G, Wang D, Xiong F, Wang Q, et al The emerging roles of CEACAM6 in human cancer (Review).
Int J Oncol. 2024;64:27. PubMedAbstract available
December 2023
SHIE WY, Chu PH, Kuo MY, Chen HW, et al Acidosis promotes the metastatic colonization of lung cancer via remodeling of
the extracellular matrix and vasculogenic mimicry.
Int J Oncol. 2023;63:136. PubMedAbstract available
November 2023
HU X, Ren J, Xue Q, Luan R, et al Anti?PD?1/PD?L1 and anti?CTLA?4 associated checkpoint inhibitor pneumonitis in
non?small cell lung cancer: Occurrence, pathogenesis and risk factors (Review).
Int J Oncol. 2023;63:122. PubMedAbstract available